Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)

Research Article

Research Results in Pharmacology 4(2): 47-58
https://doi.org/10.3897/rrpharmacology.4.27709 (20 Jun 2018)

Other versions:

Article title
Abstract
Keywords
Introduction
Objective
Materials and methods
Results and discussion
- Comparative analysis of patients’ population
- Analysis of the prescription rates dynamics of secondary prevention drugs in patients with stable angina
- Analysis of the prescription rates dynamics of antiplatelet agents
- Analysis of the prescription rates dynamics of statins
- Analysis of the prescription rates dynamics of ACE inhibitors and angiotensin II receptor antagonists
- Analysis of the prescription rates dynamics of anti-ischemic drugs in patients with stable angina
- Analysis of the prescription rates dynamics of beta-adrenoblockers
- Analysis of prescription rates dynamics of calcium channel blockers
- Analysis of the prescription rates dynamics of long-acting nitrates
- Analysis of the prescription rates dynamics of other anti-ischemic drugs
- Analysis of dynamics of specialists’ attention to modifiable risk factors
Conclusion
Conflict of interests
References
Author Contributors

Powered by

This website uses cookies in order to improve your web experience. Read our Cookies Policy

OK

Web
Analytics